During the past decade, Cardiology, PC conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiology, PC" #1 sponsor was "Juventas Therapeutics, Inc." with 5 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Losordo, Douglas, M.D." with 3 trials sponsored, "Lisata Therapeutics, Inc." with 2 trials sponsored and "Vericel Corporation" with 2 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology, PC" #1 collaborator was "Angiotech Pharmaceuticals" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology, PC" are "Critical Limb Ischemia" (7 trials), "Heart Failure" (5 trials), "Hypertension" (5 trials), "Peripheral Vascular Disease" (5 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Cardiology, PC" in a lesser frequency.

Most popular intervention types in "Cardiology, PC" are "Device" (17 trials), "Biological" (16 trials), "Drug" (11 trials), "Other" (6 trials) and "Genetic" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Ixmyelocel-T" (2 trials), "0.9% normal saline" (1 trials), "10 x 10^6 cells" (1 trials) and "2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology, PC" are 49 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology, PC". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Cardiology, PC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology, PC, 10 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".